Morgan Kohler Drug Discovery Online Articles

1. Finding The Therapeutic Window: Using Single-Cell Biology To Build More Selective T-Cell Engagers 10/6/2026

   Cyril Konto, MD, discusses Shennon Biotechnologies programs in small cell lung cancer, ovarian cancer, and hepatocellular carcinoma, and spans antibody and TCR-based T-cell engagers.